References
1.
Holliday SM, Benfield P: Venlafaxine: A review of its pharmacology and therapeutic potential in depression. Drugs 1995;49:280–294.
2.
Masood GR, Karki SD, Patterson WR: Hyponatremia with venlafaxine. Ann Pharmacother 1998;32:49–51.
3.
Gupta AK, Saravay SM: Venlafaxine-induced hyponatremia. J Clin Psychopharmacol 1997;17:223–225.
4.
Meynaar IA, Peeters AJ, Mulder AH, Ottervanger JP: Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine. Neth J Med 1997;50:243–245.
5.
Ranieri P, Franzoni S, Rozzini R, Trabucchi M: Venlafaxine-induced reset osmostat syndrome: Case of a 79-year-old depressed woman. J Geriatr Psychiatry Neurol 1997;10:75–78.
6.
Liamis GL, Milionis HJ, Rizos EC, Siamopoulos KC, Elisaf MS: Mechanisms of hyponatraemia in alcohol patients. Alcohol Alcohol 2000;35:612–616.
7.
Spigset O, Hedenmalm K: Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf 1995;12:209–225.
8.
Boyd IW: Comment: Hyponatremia with venlafaxine. Ann Pharmacother 1998;32:981–982.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
